To further elucidate mechanisms involved in mast cell accumulation at sites of cutaneous inflammation, we have studied the ability of human leukemic mast cells (HMC-1 cells) to express functionally active IL-8 receptors, Expression of mRNA for both types of IL-8 receptors (CXCR1 and CXCR2) was demonstrated by PCR and of both proteins by how cytometry, Binding and competition studies with I-125-labeled IL-8 and its homologue melanoma growth stimulating activity (I-125-labeled MGSA) revealed two specific binding sites for IL-8, K-1 = 1.1 x 10(11) M-1 and K-2 = 5 x 10(7) M-1; and for MGSA, K-1 = 2.8 x 10(10) M-1 and K-2 = 5 x 10(7) M-1. This finding was supported by a dose-dependent rise of cytosolic free calcium concentration ([Ca2+](i)) induced by both chemokines and to a lesser extent by the homologue neutrophil-activating peptide-2 (NAP-2), A significant migratory response of human leukemic mast cells (HMC-1) was observed with all three chemokines at a range from 10(-8) M to 10(-9) M. Moreover, the formation of cellular F-actin was induced in a rapid, dose-dependent fashion, with a maximally 1.7-fold increase at 10(-7) M. Using postembedding immunoelectron microscopy, we could show the expression of CXCR1 on the cytoplasmatic membrane of isolated human skin mast cells whereas CXCR2 was located in mast cell-specific granules, These findings demonstrate for the first time the functional expression of both types of IL-8 receptors on human mast cells, suggesting a role for their ligands during mast cell activation and recruitment.